Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,706 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
miR-145 promoted anoikis resistance in tumor endothelial cells.
Hida K, Kawamoto T, Maishi N, Morimoto M, Akiyama K, Ohga N, Shindoh M, Shinohara N, Hida Y. Hida K, et al. Among authors: morimoto m. J Biochem. 2017 Aug 1;162(2):81-84. doi: 10.1093/jb/mvx033. J Biochem. 2017. PMID: 28510655
Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance.
Hida K, Maishi N, Akiyama K, Ohmura-Kakutani H, Torii C, Ohga N, Osawa T, Kikuchi H, Morimoto H, Morimoto M, Shindoh M, Shinohara N, Hida Y. Hida K, et al. Among authors: morimoto h, morimoto m. Cancer Sci. 2017 Nov;108(11):2195-2203. doi: 10.1111/cas.13388. Epub 2017 Sep 17. Cancer Sci. 2017. PMID: 28851003 Free PMC article.
Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome.
Kikuchi H, Maishi N, Annan DA, Alam MT, Dawood RIH, Sato M, Morimoto M, Takeda R, Ishizuka K, Matsumoto R, Akino T, Tsuchiya K, Abe T, Osawa T, Miyajima N, Maruyama S, Harabayashi T, Azuma M, Yamashiro K, Ameda K, Kashiwagi A, Matsuno Y, Hida Y, Shinohara N, Hida K. Kikuchi H, et al. Among authors: morimoto m. Cancer Res. 2020 Jul 15;80(14):2996-3008. doi: 10.1158/0008-5472.CAN-19-3791. Epub 2020 Jun 14. Cancer Res. 2020. PMID: 32536602
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.
Maishi N, Sakurai Y, Hatakeyama H, Umeyama Y, Nakamura T, Endo R, Alam MT, Li C, Annan DA, Kikuchi H, Morimoto H, Morimoto M, Akiyama K, Ohga N, Hida Y, Harashima H, Hida K. Maishi N, et al. Among authors: morimoto h, morimoto m. Cancer Sci. 2022 May;113(5):1855-1867. doi: 10.1111/cas.15323. Epub 2022 Mar 21. Cancer Sci. 2022. PMID: 35266253 Free PMC article.
1,706 results